- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
- Publication of 2012 half-year financial report
- Increase in total operating performance
- Equity ratio of 88%
Nanostart AG, a leading nanotechnology investment company, generated EBITDA adjusted for non-recurring items of €1,064k in the first half of 2012. This represents a 10% increase as compared to the same period of the previous year (€967k).
Total operating performance was improved by 9% to €2,395k as against the first half of 2011. This includes income from sales of financial assets, particularly from the off-market sale of share in the equity investment MagForce AG. In addition, income from loans of financial assets and interest and similar income in the amount of €724k (previous year: €628k) made a positive contribution to earnings.
As of the end of the first half of the year, a write-down of €4,028k (previous year: €0) was recognized on financial assets. This relates to the carrying amount and the shareholder loans granted to the equity investment Holmenkol, and results in a net loss for the half-year period under the German Commercial Code (HGB) in the amount of €2,370k (previous year: net profit of €1,537 thousand).
Equity decreased from €37,485k at the end of 2011 to €35,115k. However, the equity ratio remains at a high level of 88% (previous year: 90%).
Operating activities in the first half of 2012 focused on stepping up business in Asia and further development of the largest portfolio-holding MagForce AG.
The half-year financial statement 2012 is now available in the Investor Relations section of the Nanostart website under "Company Reports".
About Nanostart AG
Nanostart AG (OTCQX: NASRY) headquartered in the German financial capital of Frankfurt, is a leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. As main shareholder of Nanostart Asia Pacific Ptd Ltd, Nanostart invests as partner of the Singaporean government.
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia or Japan.
For more information, please click here
Dr. Hans Joachim Duerr
Head of Corporate Communications
60313 Frankfurt, Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 150
Copyright © Nanostart AGIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
BESSTECH Announces $250K Investment from Eastern New York Angels : Funding will accelerate commercialization of BESSTECH’s innovative lithium-ion battery electrode technology and enable hiring of key personnel May 13th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Arrowhead to Present at Jefferies 2015 Healthcare Conference May 27th, 2015
FEI Company: Strong Growth Prospects Remain May 1st, 2015